safety profile – Page 11 – Communicable Diseases Research

[Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19

Research article

Published on 2022-02-012022-10-05
Journal: Actas Dermo-Sifiliográficas [Category] 치료제,

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience

심장 이식 환자에게 BNT162b2 백신 3차 접종: 면역원성과 임상 경험

Article

Published on 2022-02-012022-09-12
Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] adverse events anti-RBD Anti-RBD antibody BNT162b2 BNT162b2 vaccine booster booster dose C-reactive protein cellular immune responses clinical experience Cohort COVID-19 COVID-19 pandemic defined domain dose elicited Heart transplantation homologous humoral IgG IgG anti-RBD immune response Immunocompromised immunogenicity increase in injection investigated likelihood majority Mild mycophenolate Neutralizing antibodies neutralizing antibody neutralizing capacity Pain Patient patients Pfizer populations positive antibody response primary doses RBD recipients reduced rejection repeated safety profile SARS-CoV-2 neutralization second dose Serious Adverse Event Specific T-cell response subset T cell response the vaccine Tolerability vaccine response vaccine-induced antibody response were assessed were recorded
[DOI] 10.1016/j.healun.2021.08.010 PMC 바로가기 [Article Type] Article

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

암 환자에 대한 COVID-19 백신의 효능 및 안전성 프로파일: 전향적, 다기관 코호트 연구

Multicenter Study

Published on 2022-01-272022-09-12
Journal: Future Oncology [Category] MERS, SARS, 진단,

[키워드] affecting antibody Blood blood sample Cancer cancer patient Cancer patients cancer treatment Chemotherapy Control control group CoronaVac COVID-19 COVID-19 vaccine COVID-19 vaccines defined disease disrupting dose effective Efficacy and safety evaluate evaluated Factor high risk highlight IgG IgG antibody immune response Immunotherapy inactivated Inactivated vaccine inactive infection with SARS-CoV-2 levels of antibodies malignancy marker multicenter cohort study Older Patient PROTECT receiving safety profile SARS-CoV-2 SARS-CoV-2 vaccination seropositive significantly lower spike the patient the vaccine vaccination Vaccine virus volunteers were measured
[DOI] 10.2217/fon-2021-1248 PMC 바로가기 [Article Type] Multicenter Study

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease

Article

Published on 2022-01-272022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Homologous and Heterologous Covid-19 Booster Vaccinations

Original Article

Published on 2022-01-262022-11-01
Journal: The New England Journal of Medicine [Category] COVID-19, Fulltext, SARS,

[키워드] acute respiratory syndrome Ad26.COV2.S Ad26.COV2.S vaccine antibody assigned binding BNT162b2 booster Booster vaccine Breakthrough infection CD8+ T cell CD8+ T-cell clinical trial combinations conducted coronavirus coronavirus disease dose effective Emergency use authorization enrolled had no headache Heterologous homologous humoral immunogenicity immunogenic Infection injection Injection-site pain malaise Moderna mRNA vaccine mRNA-1273 myalgia Neutralizing antibody titer Neutralizing titer Open-label participant Pfizer–BioNTech primary end point pseudovirus reactogenicity receive recipient recipients regimen reported Result safety profile SARS-CoV-2 SARS-CoV-2 D614G T-cell Response the United State The United States Trial Vaccine virus particles
[DOI] 10.1056/NEJMoa2116414 PMC 바로가기 [Article Type] Original Article

Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches

Review Article

Published on 2022-01-232022-10-31
Journal: Heliyon [Category] COVID-19,

Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials

COVID-19를 예방하기위한 백신 : 무작위 임상 시험의 시험 순차 분석 및 네트워크 메타 분석을 통한 살아있는 체계적인 검토

Meta-Analysis

Published on 2022-01-212022-09-10
Journal: PLoS ONE [Category] meta-analysis, 임상,

[키워드] 95% CI 95% confidence interval all-cause mortality analyses Analysis CENTRAL certainty certainty of evidence clinical trials comparable conducted confidence interval COVID-19 COVID-19 vaccine COVID-19 vaccines database databases decreased mortality effective Effective vaccines Effectiveness Efficacy events Evidence evidence of Follow-up GRADE inactivated Inactivated vaccine Inactivated Vaccines inception increased the risk independent meta-analyses Meta-analysis moderate mRNA mRNA vaccine mRNA vaccines Network meta-analysis non-serious adverse non-serious adverse events participant Prevent prevented Primary outcome protein subunit vaccine Protein subunit vaccines randomized clinical trial randomized clinical trials randomizing reducing mortality risk risk ratio risks of bias safety profile screened searched Serious Adverse Events subunit vaccines suggested systematic review the vaccine the vaccines Trial trial sequential analyses trials TSA Vaccine vaccine efficacy Vaccines Viral Viral vector vaccine Viral vector vaccines
[DOI] 10.1371/journal.pone.0260733 PMC 바로가기 [Article Type] Meta-Analysis

Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19

Article

Published on 2022-01-172022-10-28
Journal: Vaccines [Category] COVID-19,

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Infectious Disease

Published on 2022-01-152022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 95% CI 95% confidence interval absence adjusted age Analysis analyzed approval automatically baseline Brazil clinical Cohort Comorbidities conducted contraindications coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 mortality death demonstrated dose Efficacy evaluate Hospitalization infected patient Infection infection rate information Ivermectin matching material mechanism medication mortality rate mortality rates occurred offered outcome prevention propensity score matching Prophylactic Prophylaxis Prospective PROTECT PSM real time reduced reduction in reduction in mortality registry data reported safety profile SARS-CoV-2 score Sex significantly subject subsequent Treatment variables were infected with COVID-19
[DOI] 10.7759/cureus.21272 PMC 바로가기 [Article Type] Infectious Disease

A Case of Acute Viral Pericarditis Complicated With Pericardial Effusion Induced by Third Dose of COVID Vaccination

Emergency Medicine

Published on 2022-01-132022-10-31
Journal: Cureus [Category] COVID-19,